Postdoc @Marsonlab @GladstoneInst @UCSF | PhD in Virology with @jkagan1 @harvardmed | Interest in Mechanistic Immunology, Cell Biology, Synthetic Biology

Joined July 2021
27 Photos and videos
Pascal Devant retweeted
More than thrilled to share that I’ve been promoted to full (tenured) Professor @harvardmed @Harvard. This only happened because of the hard work of many people, but I want to dedicate this promotion to my grandmas, Nonna Maria & Nonna Vevè. A #FirstGen thread 🧵 1/x
59
20
526
21,767
Pascal Devant retweeted
New Lab Alert! I am thrilled to share that next month I am starting my new role as an Assistant Professor at The Wistar Institute. I am extremely excited to work with fantastic new colleagues at Wistar and collaborate with researchers across UPenn.
7
1
65
6,580
Pascal Devant retweeted
Excited to share an amazing video on the NLRP3 inflammasome pathway generated by talented Ann from the Iwasa lab @janetiwasa @Ann_HuiLiu. It shows the real cryo-EM structures of the pathway from #NLRP3, #ASC, #caspase-1, #GSDMD, #IL-1b, to #NINJ1. #cryoem @LeXiao17 Enjoy
7
56
240
19,046
Pascal Devant retweeted
Excited to share that my PhD work on ER mito contact sites is finally out at @MolecularCell! Big shout out to @stark2_d to take this across the finish line, and @YatrikShahLab and @LyssiotisLab for their guidance as always!
Online Now: BRD4-mediated ER membrane contact creates functionally distinct mitochondrial subtypes dlvr.it/TQxTPQ
16
27
81
13,284
Pascal Devant retweeted
Together with Emma Dann, we are thrilled to present a massive new Perturb-seq atlas of 22M primary CD4 T cells, from 4 donors, across 3 timepoints – the result of a decade-long collaboration between the Marson (@MarsonLab) and Pritchard (@jkpritch) labs. 🧵👇
4
52
242
39,285
Pascal Devant retweeted
We are excited to share our new @CellCellPress paper revealing mechanisms of action of promising drugs against the helicase–primase of herpes simplex virus 1 (HSV-1) 🤩@HarvardMicro cell.com/cell/fulltext/S0092…
6
11
17
1,089
Pascal Devant retweeted
Replying to @biorxivpreprint
@biorxivpreprint Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells biorxiv.org/content/10.64898… @HyuncheolJung @pascal_devant @Marsonlab @GladstoneInst @UCSF @jccarnevale
2
10
765
Pascal Devant retweeted
Another exciting paper from @GladstoneInst Genomic Immunology - check out our latest preprint on myeloid cell editing: Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells, led by @HyuncheolJung and @pascal_devant
1
9
14
6,272
Excited to share the first Co-First author manuscript from my postdoc in the Marson lab @GladstoneInst Great collaboration with @HyuncheolJung from @jccarnevale lab @UCSF on CRISPR editing and screening in primary human myeloid cells! See tweetorial below! biorxiv.org/content/10.64898…
Another exciting paper from @GladstoneInst Genomic Immunology - check out our latest preprint on myeloid cell editing: Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells, led by @HyuncheolJung and @pascal_devant
4
3
16
3,670
Pascal Devant retweeted
New preprint from the lab from PhD student Seb Grant. Started as a summer side project and developed into an exciting story. Evolutionary convergence of a Pyroptosis-Apoptosis crosstalk drives non-canonical inflammasome signalling. biorxiv.org/content/10.1101/…
2
3
10
457
Pascal Devant retweeted
Check out our latest work led by two talented postdocs, Madhura and Chris @TheBourneImmuno. We find that CASP4/5 can cleave and activate CASP3/7, acting as initiators of both pyroptosis and apoptosis. Notably, both are needed for full pathogen defense! biorxiv.org/content/10.1101/…
1
3
14
793
Pascal Devant retweeted
meta-PAMPs: A new class of immunostimulatory molecules that control the ability of bacterial factors to operate as PAMPs. Jordan Jastrab reveals that wall teichoic acid (WTA) is a key regulator of inflammasomes and interferons during infection. biorxiv.org/content/10.1101/…
5
11
53
3,742
Pascal Devant retweeted
21 Aug 2025
#InterferonPower! Thrilled for our latest work @CellCellPress! With @dfrboehmer, we dug into tons of papers & created what we hope will be a go-to resource for immunologists & non-immunologist about type I, II, III (& IV😉) #interferons! Free link 👉 authors.elsevier.com/a/1leKG…
13
119
398
33,855
Pascal Devant retweeted
Everything you wanted to know about oxidized lipids & immunity, in one review. We explain how oxidized lipids impact inflammation, dendritic cells, anti-tumor immunity and more. Kudos to Joon Choi for his exceptional work. @harvardmed @BostonChildrens royalsocietypublishing.org/d…
18
92
5,996
RT @ShiyuXia: In January 2026, I will be joining Berkeley @UCBerkeley as an Assistant Professor in the Department of Chemical and Biomolecu…
10
1
Pascal Devant retweeted
Chris's @TheBourneImmuno paper is online now. Huge thanks to @BookerMan_PSU for coordinating this special Juneteenth issue @ACSPublications ACS Bio & Med Chem Au. Congrats to our growing lab and all who contributed. Happy 4th everyone!! pubs.acs.org/doi/full/10.102…
1
5
34
1,714